MYC-dependent downregulation of telomerase by FLT3 inhibitors is required for their therapeutic efficacy on acute myeloid leukemia
Crossref DOI link: https://doi.org/10.1007/s00277-017-3158-8
Published Online: 2017-10-27
Published Print: 2018-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Xiaolu
Li, Bingnan
Yu, Jingya
Dahlström, Jenny
Tran, Anh Nhi
Björkhom, Magnus
Xu, Dawei
Funding for this research was provided by:
Karolinska Institute
License valid from 2017-10-27